文献速递神经PET

痴呆症β-淀粉样蛋白脑PET影像的定量评估:两种商用软件包与临床报告的比较

Quantitative evaluation of beta-amyloid brain PET imaging in dementia: a comparison between two commercial software packages and the clinical report.
PubMed 文献 · Br J Radiol · 2019-05-08

该研究对225例18F-Florbetapir PET扫描分别用Hermes BRASS和Siemens Syngo.VIA两种商用软件定量,并与临床医师报告比较。81%扫描为Type A(典型特征),19%为非Type A(非典型特征)。BRASS对Type A敏感度98.8%、特异度73%,Syngo.VIA敏感度96.3%、特异度92%;对非Type A,BRASS敏感度95.8%、特异度36.8%,Syngo.VIA敏感度79.2%、特异度57.9%。作者认为Syngo.VIA与临床报告一致性更好,替代阈值和分类可能改善一致性,更复杂方案被推荐。

要点

  • BRASS阳性标准为2个及以上感兴趣区z-score≥2,Type A敏感度98.8%但特异度仅73%。
  • Syngo.VIA阳性标准为平均皮层SUVR≥1.17,Type A敏感度96.3%、特异度92%。
  • 非Type A扫描两种软件特异度均低(BRASS 36.8%、Syngo.VIA 57.9%)。

核心结论

  • Hermes BRASS阳性标准敏感度高但特异度低,Siemens Syngo.VIA敏感度和特异度均较高且与临床报告一致性更好;替代阈值和分类可能改善与临床报告的一致性,更复杂方案被推荐。

研究设计与样本

  • 研究论文,比较商用图像分析工具Hermes BRASS和Siemens Syngo.VIA与临床评估在18F-Florbetapir PET扫描中的表现,共225例扫描由临床医师报告并用两种软件包定量。

关键影像表现/征象

  • 扫描分为Type A(典型特征)和非Type A(非典型特征),阳性和阴性扫描均适用此分类。
  • 81%扫描为Type A,19%扫描为非Type A。

诊断标准与关键数值

  • BRASS阳性标准:2个及以上感兴趣区z-score≥2。
  • Syngo.VIA阳性标准:平均皮层标准化摄取值比(mcSUVR)≥1.17。
  • Type A扫描:BRASS敏感度98.8%、特异度73%;Syngo.VIA敏感度96.3%、特异度92%。
  • 非Type A扫描:BRASS敏感度95.8%、特异度36.8%;Syngo.VIA敏感度79.2%、特异度57.9%。
  • Syngo.VIA推荐第三个可识别斑块水平阈值(1.08≤mcSUVR≤1.17)以增加假阴性扫描的检出。

临床应用与阅片要点

  • 软件包可能辅助临床报告更难解读、需要更有经验阅片者的病例。
  • BRASS采用替代阳性阈值mcSUVR≥1.18时假阳性率显著下降。
  • 引入替代标准未改善非Type A扫描的预测结果。

局限性

  • 引入替代标准未改善非Type A扫描的预测结果,更复杂方案被推荐。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To compare commercially available image analysis tools Hermes BRASS and Siemens Syngo.VIA with clinical assessment in 18F-Florbetapir PET scans.

METHODS: 225 scans were reported by clinicians and quantified using two software packages. Scans were classified into Type A (typical features) or non-Type A (atypical features) for both positive and negative scans. For BRASS, scans with z-score ≥ 2 in 2 ≥ region of interest were classed positive. For Syngo.VIA a positive scan was indicated when mean cortical standardized uptake value ratio (mcSUVR) ≥ 1.17.

RESULTS: 81% scans were Type A, and 19% scans were non-Type A. The sensitivity of BRASS and Syngo.VIA for Type A scans was 98.8 and 96.3%, specificity was 73 and 92%, respectively. Sensitivity for non-Type A scans was 95.8 and 79.2%, specificity was 36.8 and 57.9%, respectively.A third threshold of identifiable levels of plaque (1.08 ≤ mcSUVR ≤ 1.17) was recommended for Syngo.VIA to increase detection of false negative scans.The false positive rate of BRASS significantly decreased when an alternative positive threshold value of mcSUVR ≥ 1.18.Introduction of alternative criteria did not improve prediction outcome for non-Type A scans. More complex solutions are recommended.

CONCLUSION: Hermes criteria for a positive scan leads to a high sensitivity but a low specificity. Siemens Syngo.VIA criteria gives a high sensitivity and specificity and agrees better with the clinical report. Alternative thresholds and classifications may help to improve agreement with the clinical report.

ADVANCES IN KNOWLEDGE: Software packages may assist with clinical reporting of more difficult to interpret cases that require a more experienced read.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Curry S, Patel N, Fakhry-Darian D, et al. Quantitative evaluation of beta-amyloid brain PET imaging in dementia: a comparison between two commercial software packages and the clinical report. Br J Radiol. 2019. PMID: 31017466. doi:10.1259/bjr.20181025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。